CONTINUOUS-FLOW LEFT ventricular assist device (LVAD) therapy has improved survival
in patients with endstage heart failure refractory to medical therapy, and as a consequence …

Recent technologic advances have resulted in the availability of percutaneous and
minimally invasive surgical devices for temporary mechanical circulatory support. These …

Objective To describe the authors' experience and comparative results after introducing
noncardiac fellowship-trained anesthesiologists to a service previously managed by …

Ventricular assist devices (VADs) provide circulatory support for patients with end-stage
heart failure. Ventricular assist devices can provide temporary or long-term support for the …

Left ventricular assist devices are implanted in patients with chronic left heart failure
refractory to maximal medical therapy. These devices were initially meant as bridge-to …

Ventricular assist devices (VADs) are mechanical devices used to support cardiac function
in patients with refractory heart failure. Although heart transplantation is the definitive …

1 Jentzer JC, Vallabhajosyula S, Khanna AK, et al. Management of refractory vasodilatory
shock. Chest 2018; 154: 416–26. 2 Levy B, Fritz C, Tahon E, et al. Vasoplegia treatments …

CONTINUOUS-FLOW LEFT VENTRICULAR assist devices (LVADs) are a mainstay of
therapy for end-stage leftheart failure. 1–4 Due to the survival benefits of LVAD treatment (1 …

The number of patients with advanced heart failure that has become unresponsive to
conventional medical therapy is increasing rapidly. One of the most promising new …

30 Millionen Menschen sind weltweit von einer Herzinsuffizienz betroffen, neben der hohen
Mortalitätsrate geht diese mit großen sozioökonomischen Kosten einher. Nachdem sich …